New potato processing technique slows starch digestion to avoid blood sugar spikes

NewsGuard 100/100 Score

Researchers announced early tests of a new potato processing technique designed to make our bodies digest potato starch more slowly. Laboratory demonstrations show that the approach blocks certain digestive enzymes from reaching the potato starch as quickly, leading to a more controlled release of dietary glucose.

There is a perception that potato foods are unhealthy because eating a large amount of some potato foods can cause a rapid increase in blood sugar, which is a risk for people with diabetes or those who want to control body weight. Our team revealed that toggling the accessibility of two digestion enzymes -; α-amylase and mucosal α-glucosidase -; in the small intestine is a successful strategy to make dietary glucose slowly and continuously release from potatoes."

Amy Lin, PhD, study's principal investigator and lead of the Food Carbohydrate Program of the Singapore Institute of Food and Biotechnology Innovation (SIFBI) at A*STAR

Andrea Gomez Maqueo Cerecer, postdoctoral research fellow at A*STAR, will present the findings online at NUTRITION 2022 LIVE ONLINE, the flagship annual meeting of the American Society for Nutrition held June 14-16. The study was supervised by Lin, and other research team members included Grace Ng, Ru Min Bek and Jei Xi Wong.

For the new processing technique, researchers cut potatoes into cubes and blanched them in hot water with a food grade ingredient for 30 minutes. The ingredient used in the solution has been designated "generally recognized as safe," a standard established by the U.S. Food and Drug Administration for substances considered safe for use in food.

This process causes a reaction with pectin, a water-soluble fiber in potatoes, creating a gelling structure that acts as a barrier between starch granules and digestive enzymes. This protective layer is porous, and the processing method allows the size of the pores to be controlled to moderate how quickly α-amylase is able to penetrate the potato parenchyma cells and degrade starch to small molecules. Converting starch molecules to glucose relies on mucosal α-glucosidase, which is too big to penetrate those pores. Therefore, the elevation of dietary glucose of processed potatoes depends on the how quickly small starch molecules leach out of parenchyma cells and are digested by mucosal α-glucosidase.

"Without our treatment, enzymes move freely in and out of cells, and starch is quickly degraded by both enzymes and rapidly converted to glucose," said Lin. "The treatment allows the starch to be slowly degraded to prevent a spike in glycemia and then fully converted to glucose to meet our energy and nutritional needs."

The technique is not designed to prevent the potato from being digested, but rather to slow digestion to avoid a rapid increase in blood sugar. Researchers say the modification could also help consumers feel full for a longer period after eating the treated potatoes, helping to avoid overeating.

Researchers report that the method performed well in tests with a simulated digestion process in the laboratory. Treatment increased the fraction of the starch that is considered slowly digestible from 10% to 35% and significantly reduced the ability for the enzyme a-amylase to access starch within the cell walls.

Since the process essentially pre-cooks the potatoes, treated potatoes are not shelf-stable but could be frozen and then cooked or further processed for dishes such as roasted potatoes, hash browns, soups or stir-fry, researchers say. Initial taste tests had good results in terms of digestibility and texture.

As a next step, the researchers are preparing to further test impacts on digestibility in a clinical trial. They also plan to study whether a similar approach could be used to improve other staple foods.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Does diabetes increase the risk of long COVID?